Showing results (51-60 of 287) with videos related to
Sort By:
Pageof 29
Journal of Neuroimmunology|July 1, 1985
Anti-idiotypic antibodies, acetylcholine receptor antibodies and disturbed neuromuscular function in healthy relatives to patients with myasthenia gravisA K Lefvert, R Pirskanen, E SvanborgJournal of Neurosurgery|December 1, 1990
Evidence of a local immune activation in cystic brain tumorsJ Boethius, A K Lefvert, A SidénClinical and Experimental Immunology|October 1, 1986
Periductal lymphocytic infiltrates in salivary glands in myasthenia gravis patients lacking Sjögren's syndromeG Lindahl, A K Lefvert, E HedforsMuscle & Nerve|September 1, 1978
Acetylcholine receptor antibodies in the diagnosis of human and experimental myasthenia gravisE Heilbronn, A K Lefvert, E StålbergActa Neurologica Scandinavica|July 21, 1998
Treatment of myasthenia gravis with methylprednisolone pulse: a double blind studyC Lindberg, O Andersen, A K LefvertBlood|April 18, 1998
Idiotype immunization combined with granulocyte-macrophage colony-stimulating factor in myeloma patients induced type I, major histocompatibility complex-restricted, CD8- and CD4-specific T-cell responsesA Osterborg, Q Yi, L Henriksson, et al.Journal of Neuroimmunology|March 1, 1981
Binding properties and subclass distribution of anti-acetylcholine receptor antibodies in myasthenia gravisA K Lefvert, S Cuénoud, B W FulpiusCell Biophysics|August 1, 1992
The clinical significance of HAMA in patients treated with mouse monoclonal antibodiesJ E Frödin, A K Lefvert, H MellstedtClinical Immunology and Immunopathology|November 1, 1987
Characterization of anti-acetylcholine receptor antibody activity in patients with anti-mitochondrial antibodiesA C Sundewall, A K Lefvert, R NorbergCancer Research|August 15, 1990
Pharmacokinetics of the mouse monoclonal antibody 17-1A in cancer patients receiving various treatment schedulesJ E Frödin, A K Lefvert, H MellstedtPageof 29